<DOC>
	<DOC>NCT00898716</DOC>
	<brief_summary>The purpose of this clinical study is to establish the maximum tolerated dose of BMS-754807 when administered orally on a once daily schedule in subjects with solid tumors.</brief_summary>
	<brief_title>Multiple Ascending Dose Study of BMS-754807 in Patients With Solid Tumors in Japan</brief_title>
	<detailed_description />
	<criteria>Advanced or metastatic solid tumors for whom the standard of care is ineffective or inappropriate Life expectancy of at least 3 months Eastern Cooperative Oncology Group performance 01 Any disorder with dysregulation of glucose homeostasis Dumping syndrome History of glucose intolerance</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2010</verification_date>
</DOC>